[A double blind study of rifampicin].
D002511:Cephalosporins / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002511:Cephalosporins; D010880:Piperidines; D012293:Rifampin